Key Highlights:
- Piramal Pharma Solutions launched a state-of-the-art spray drying suite at its peptide development and manufacturing facility in Turbhe, India, to support formulation of peptides and other complex molecules.
- The closed-loop, ISO Class 8-compliant facility supports high-potency compounds up to Band 5 containment, enabling precise particle control, improved bioavailability, and safe processing of sensitive peptide formulations.
- The expansion strengthens PPS’s peptide manufacturing capabilities, helping drug developers accelerate the development of stable, high-quality peptide therapies across multiple therapeutic areas.
Implications:
The expansion makes Turbhe more competitive for high-potency peptides, HPAPIs, and biomolecules, helping Piramal attract programs that need safe, small-batch spray drying with tight containment and ISO Class 8 conditions. This can shorten development timelines, support more robust formulations, and broaden the types of peptide and complex-drug projects Piramal can win, especially as sponsors look for CDMOs with advanced particle-engineering capabilities in India.
Source: PRnewswire
